Connection

Kenneth Tew to Drug Resistance

This is a "connection" page, showing publications Kenneth Tew has written about Drug Resistance.
Connection Strength

1.041
  1. Coordinate changes in expression of protective genes in drug-resistant cells. Chem Biol Interact. 1998 Apr 24; 111-112:199-211.
    View in: PubMed
    Score: 0.143
  2. Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification. Drug Metab Rev. 2011 May; 43(2):179-93.
    View in: PubMed
    Score: 0.087
  3. Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines. J Biol Chem. 1990 Mar 15; 265(8):4296-301.
    View in: PubMed
    Score: 0.082
  4. Glutathione, glutathione S-transferases, and related redox enzymes in Adriamycin-resistant cell lines with a multidrug resistant phenotype. Cancer Commun. 1989; 1(2):133-9.
    View in: PubMed
    Score: 0.075
  5. Identification of a novel first exon of the human ABCA2 transporter gene encoding a unique N-terminus. Biochim Biophys Acta. 2004 Apr 16; 1678(1):22-32.
    View in: PubMed
    Score: 0.054
  6. Increased expression of DNA-dependent protein kinase confers resistance to adriamycin. Biochim Biophys Acta. 1998 Jul 23; 1381(2):131-8.
    View in: PubMed
    Score: 0.036
  7. Glutathione and drug resistance. Cancer Invest. 1996; 14(2):158-68.
    View in: PubMed
    Score: 0.031
  8. Glutathione S-transferases. Cancer Treat Res. 1996; 87:83-122.
    View in: PubMed
    Score: 0.031
  9. Modulation of glutathione and related enzymes in reversal of resistance to anticancer drugs. Hematol Oncol Clin North Am. 1995 Apr; 9(2):383-96.
    View in: PubMed
    Score: 0.029
  10. Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells. Mol Pharmacol. 1994 Nov; 46(5):866-72.
    View in: PubMed
    Score: 0.028
  11. Pharmakokinetics and bioavailability study of ethacrynic acid as a modulator of drug resistance in patients with cancer. J Pharmacol Exp Ther. 1994 Sep; 270(3):1186-91.
    View in: PubMed
    Score: 0.028
  12. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 1994 Aug 15; 54(16):4313-20.
    View in: PubMed
    Score: 0.028
  13. Regulation of human dihydrodiol dehydrogenase by Michael acceptor xenobiotics. J Biol Chem. 1994 Jun 03; 269(22):15558-62.
    View in: PubMed
    Score: 0.027
  14. P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine. J Natl Cancer Inst. 1994 May 04; 86(9):688-94.
    View in: PubMed
    Score: 0.027
  15. Overproduction of a 37.5-kDa cytosolic protein structurally related to prostaglandin F synthase in ethacrynic acid-resistant human colon cells. Mol Pharmacol. 1993 Jun; 43(6):845-53.
    View in: PubMed
    Score: 0.026
  16. Time course of glutathione S-transferase elevation in Walker mammary carcinoma cells following chlorambucil exposure. Biochem Pharmacol. 1993 Feb 09; 45(3):683-90.
    View in: PubMed
    Score: 0.025
  17. Increased levels of glutathione S-transferase pi transcript as a mechanism of resistance to ethacrynic acid. Biochem J. 1992 Jan 01; 281 ( Pt 1):219-24.
    View in: PubMed
    Score: 0.023
  18. Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype. Br J Cancer. 1991 Aug; 64(2):267-73.
    View in: PubMed
    Score: 0.022
  19. Glutathione S-transferases in normal and malignant human colon tissue. Biochim Biophys Acta. 1991 Apr 15; 1096(3):209-16.
    View in: PubMed
    Score: 0.022
  20. Detoxification mechanisms and tumor cell resistance to anticancer drugs. Med Res Rev. 1991 Mar; 11(2):185-217.
    View in: PubMed
    Score: 0.022
  21. Identification of a glutathione S-transferase associated with microsomes of tumor cells resistant to nitrogen mustards. Biochem Pharmacol. 1989 Jun 15; 38(12):1915-21.
    View in: PubMed
    Score: 0.019
  22. Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines. Cancer Res. 1988 Jul 01; 48(13):3622-5.
    View in: PubMed
    Score: 0.018
  23. Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines. Mol Pharmacol. 1987 Jun; 31(6):575-8.
    View in: PubMed
    Score: 0.017
  24. Differences in the nuclear matrix phosphoproteins of a wild-type and nitrogen mustard-resistant rat breast carcinoma cell line. Cancer Res. 1986 Sep; 46(9):4672-6.
    View in: PubMed
    Score: 0.016
  25. Selection of nitrogen mustard resistance in a rat tumor cell line results in loss of guanine-O6-alkyl transferase activity. Mol Pharmacol. 1986 Jul; 30(1):77-80.
    View in: PubMed
    Score: 0.016
  26. A comparative analysis of drug-induced DNA effects in a nitrogen mustard resistant cell line expressing sensitivity to nitrosoureas. Biochem Pharmacol. 1986 Apr 01; 35(7):1171-6.
    View in: PubMed
    Score: 0.016
  27. Poly(adenosine diphosphate-ribosylation) of nuclear matrix proteins in alkylating agent resistant and sensitive cell lines. Chem Biol Interact. 1985 Jul; 54(2):209-22.
    View in: PubMed
    Score: 0.015
  28. Increased glutathione-S-transferase activity in a cell line with acquired resistance to nitrogen mustards. Cancer Treat Rep. 1985 Jun; 69(6):677-82.
    View in: PubMed
    Score: 0.015
  29. Carbamoylation of glutathione reductase and changes in cellular and chromosome morphology in a rat cell line resistant to nitrogen mustards but collaterally sensitive to nitrosoureas. Cancer Res. 1985 May; 45(5):2326-33.
    View in: PubMed
    Score: 0.015
  30. The mechanism of action of estramustine. Semin Oncol. 1983 Sep; 10(3 Suppl 3):21-6.
    View in: PubMed
    Score: 0.013
  31. Selective cytotoxicity of haloethylnitrosoureas in a carcinoma cell line resistant to bifunctional nitrogen mustards. Mol Pharmacol. 1982 May; 21(3):729-38.
    View in: PubMed
    Score: 0.012
  32. Increase of beta(III)- and beta(IVa)-tubulin isotopes in human prostate carcinoma cells as a result of estramustine resistance. Cancer Res. 1996 Jun 01; 56(11):2584-9.
    View in: PubMed
    Score: 0.008
  33. Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer. J Clin Oncol. 1992 Nov; 10(11):1754-61.
    View in: PubMed
    Score: 0.006
  34. Interaction of forskolin with the P-glycoprotein multidrug transporter. Biochemistry. 1991 Aug 27; 30(34):8371-9.
    View in: PubMed
    Score: 0.006
  35. Determinants of drug response in a cisplatin-resistant human lung cancer cell line. Jpn J Cancer Res. 1990 May; 81(5):527-35.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.